These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20496362)

  • 1. The tubulin-bound structure of the antimitotic drug tubulysin.
    Kubicek K; Grimm SK; Orts J; Sasse F; Carlomagno T
    Angew Chem Int Ed Engl; 2010 Jun; 49(28):4809-12. PubMed ID: 20496362
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-based identification of the binding site for the hemiasterlin analogue HTI-286 on tubulin.
    Ravi M; Zask A; Rush TS
    Biochemistry; 2005 Dec; 44(48):15871-9. PubMed ID: 16313189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of 1-methyl-2-(3',4',5'-trimethoxybenzoyl)-3-aminoindoles as a new class of antimitotic agents and tubulin inhibitors.
    Romagnoli R; Baraldi PG; Sarkar T; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Hsieh HP; Hamel E
    J Med Chem; 2008 Mar; 51(5):1464-8. PubMed ID: 18260616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxadiazole derivatives as a novel class of antimitotic agents: Synthesis, inhibition of tubulin polymerization, and activity in tumor cell lines.
    Ouyang X; Piatnitski EL; Pattaropong V; Chen X; He HY; Kiselyov AS; Velankar A; Kawakami J; Labelle M; Smith L; Lohman J; Lee SP; Malikzay A; Fleming J; Gerlak J; Wang Y; Rosler RL; Zhou K; Mitelman S; Camara M; Surguladze D; Doody JF; Tuma MC
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1191-6. PubMed ID: 16377187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The betaI/betaIII-tubulin isoforms and their complexes with antimitotic agents. Docking and molecular dynamics studies.
    Magnani M; Ortuso F; Soro S; Alcaro S; Tramontano A; Botta M
    FEBS J; 2006 Jul; 273(14):3301-10. PubMed ID: 16803461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemistry and biology of tubulysins: antimitotic tetrapeptides with activity against drug resistant cancers.
    Murray BC; Peterson MT; Fecik RA
    Nat Prod Rep; 2015 May; 32(5):654-62. PubMed ID: 25677951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The high-resolution solution structure of epothilone A bound to tubulin: an understanding of the structure-activity relationships for a powerful class of antitumor agents.
    Carlomagno T; Blommers MJ; Meiler J; Jahnke W; Schupp T; Petersen F; Schinzer D; Altmann KH; Griesinger C
    Angew Chem Int Ed Engl; 2003 Jun; 42(22):2511-5. PubMed ID: 12800173
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimitotic activity of lobaric acid and a new benzofuran, sakisacaulon A from Stereocaulon sasakii.
    Morita H; Tsuchiya T; Kishibe K; Noya S; Shiro M; Hirasawa Y
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3679-81. PubMed ID: 19481447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of tubulysin, an antimitotic peptide from myxobacteria.
    Khalil MW; Sasse F; Lünsdorf H; Elnakady YA; Reichenbach H
    Chembiochem; 2006 Apr; 7(4):678-83. PubMed ID: 16491500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization.
    Romagnoli R; Baraldi PG; Carrion MD; Lopez Cara C; Preti D; Fruttarolo F; Pavani MG; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Balzarini J; Hadfield JA; Brancale A; Hamel E
    J Med Chem; 2007 May; 50(9):2273-7. PubMed ID: 17419607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The binding mode of epothilone A on alpha,beta-tubulin by electron crystallography.
    Nettles JH; Li H; Cornett B; Krahn JM; Snyder JP; Downing KH
    Science; 2004 Aug; 305(5685):866-9. PubMed ID: 15297674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Privileged structure-based quinazolinone natural product-templated libraries: identification of novel tubulin polymerization inhibitors.
    Liu JF; Wilson CJ; Ye P; Sprague K; Sargent K; Si Y; Beletsky G; Yohannes D; Ng SC
    Bioorg Med Chem Lett; 2006 Feb; 16(3):686-90. PubMed ID: 16257201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative molecular field and comparative molecular similarity indices analyses (CoMFA and CoMSIA) of N-phenyl-N'-(2-chloroethyl)ureas targeting the colchicine-binding site as anticancer agents.
    Fortin S; Labrie P; Moreau E; Wei L; Kotra LP; C-Gaudreault R
    Bioorg Med Chem; 2008 Feb; 16(4):1914-26. PubMed ID: 18023585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships of 1-benzyl-4,5,6-trimethoxyindoles as a novel class of potent antimitotic agents.
    Lai MJ; Kuo CC; Yeh TK; Hsieh HP; Chen LT; Pan WY; Hsu KY; Chang JY; Liou JP
    ChemMedChem; 2009 Apr; 4(4):588-93. PubMed ID: 19266513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new cytotoxic and tubulin-interactive milnamide derivative from a marine sponge Cymbastela sp.
    Chevallier C; Richardson AD; Edler MC; Hamel E; Harper MK; Ireland CM
    Org Lett; 2003 Oct; 5(20):3737-9. PubMed ID: 14507218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico design of tubulin-targeted antimitotic peptides.
    Pieraccini S; Saladino G; Cappelletti G; Cartelli D; Francescato P; Speranza G; Manitto P; Sironi M
    Nat Chem; 2009 Nov; 1(8):642-8. PubMed ID: 21378956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimitotic chalcones and related compounds as inhibitors of tubulin assembly.
    Ducki S
    Anticancer Agents Med Chem; 2009 Mar; 9(3):336-47. PubMed ID: 19275525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubulin-based structure-affinity relationships for antimitotic Vinca alkaloids.
    Coderch C; Morreale A; Gago F
    Anticancer Agents Med Chem; 2012 Mar; 12(3):219-25. PubMed ID: 22044006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of 7-phenyl-6,9-dihydro-3H-pyrrolo[3,2-f]quinolin-9-ones: a new class of antimitotic agents devoid of aromatase activity.
    Gasparotto V; Castagliuolo I; Chiarelotto G; Pezzi V; Montanaro D; Brun P; Palù G; Viola G; Ferlin MG
    J Med Chem; 2006 Mar; 49(6):1910-5. PubMed ID: 16539377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of vinca alkaloids and phomopsin hybrids.
    Ngo QA; Roussi F; Cormier A; Thoret S; Knossow M; Guénard D; Guéritte F
    J Med Chem; 2009 Jan; 52(1):134-42. PubMed ID: 19072542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.